Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank62
3Y CAGR-10.0%
5Y CAGR+18.7%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
-10.0%/yr
Annual compound
5Y CAGR
+18.7%/yr
Recent deceleration
Percentile
P62
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$2.23M-43.9%
2024$3.97M-45.7%
2023$7.30M+138.8%
2022$3.06M+6.6%
2021$2.87M+203.4%
2020$946000.00-8.4%
2019$1.03M-
2018$0.00-
2017$0.00-100.0%
2016$2.23M-